GridAI Technologies GRDX
NASDAQ GRDX
$3.57 -0.18 (-4.83%)
As of: Aug 21, 2026 · 3:59 PM EDT

GridAI Technologies (GRDX) Cash from Financing Activities (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Cash from Financing Activities came in at $2.2 million in Q4 2025, up 6906.66% YoY from $30890.3 in Q4 2024, and down 28.45% on a QoQ basis from $3.0 million in Q3 2025.

GridAI Technologies (GRDX) Cash from Financing Activities (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 11 years of Cash from Financing Activities data on file, last reported at $2.2 million in Q4 2025.

  • Quarterly Cash from Financing Activities rose 6906.66% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (up 5.52% YoY) and the FY2025 annual result came in at $5.9 million, up 5.52% from the prior year.
  • Cash from Financing Activities retreated to $2.2 million in Q4 2025, from $3.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $17.1 million in Q4 2021 to a low of -$31798.0 in Q4 2024.
  • A 5-year average of $4.6 million and a median of $3.4 million in 2024 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Financing Activities slumped 100.73% — and 2025, when it surged 6906.66%.
  • Tracing GRDX's Cash from Financing Activities over 5 years: stood at $17.1 million in 2021, then sank by 67.64% to $5.5 million in 2022, then dropped by 21.1% to $4.4 million in 2023, then tumbled by 100.73% to -$31798.0 in 2024, then surged by 6906.66% to $2.2 million in 2025.
  • The last three Cash from Financing Activities figures came in at $2.2 million (Q4 2025), $3.0 million (Q3 2025), and $700000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 GridAI Technologies 5.82 Mn 5.82 Mn - 2.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.16 Mn
Dec 31, 2025 2.16 Mn
Sep 30, 2025 3.03 Mn
Sep 30, 2025 3.03 Mn
Mar 31, 2025 700,000.00
Mar 31, 2025 700,000.00
Dec 31, 2024 -31,798.00
Dec 31, 2024 -31,798.00
Sep 30, 2024 1.55 Mn
Sep 30, 2024 1.55 Mn
Jun 30, 2024 681,420.00
Jun 30, 2024 681,420.00
Mar 31, 2024 3.38 Mn
Mar 31, 2024 3.38 Mn
Dec 31, 2023 4.36 Mn
Dec 31, 2023 4.36 Mn
Sep 30, 2023 5.39 Mn
Sep 30, 2023 5.39 Mn
Jun 30, 2023 1.93 Mn
Jun 30, 2023 1.93 Mn